{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:44:42Z","timestamp":1793385882770,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-016-3015-5","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T08:02:23Z","timestamp":1483603343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA"],"prefix":"10.1186","volume":"17","author":[{"given":"Nishitha","family":"Thumallapally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Meshref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terenig","family":"Terjanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"issue":"6","key":"3015_CR1","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood.V96.6.2037","volume":"96","author":"MA Dimopoulos","year":"2000","unstructured":"Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R. \u201cSolitary plasmacytoma of bone and asymptomatic multiple myeloma,\u201d. Blood. 2000;96(6):2037.","journal-title":"Blood"},{"key":"3015_CR2","doi-asserted-by":"crossref","unstructured":"Dimopoulos MA, Hamilos G. \u201cSolitary bone plasmacytoma and extramedullary plasmacytoma,\u201d CurrentTreatment Options in Oncology. 2002; p. 255-9","DOI":"10.1007\/s11864-002-0015-2"},{"issue":"1","key":"3015_CR3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1148\/radiology.135.1.7360960","volume":"135","author":"D Tong","year":"1980","unstructured":"Tong D, Griffin TW, Laramore GE, Kurtz JM, Russell AH, Groudine MT, et al. Solitary plasmacytoma of bone and soft tissues. Radiology. 1980;135(1):195\u20138.","journal-title":"Radiology"},{"issue":"4","key":"3015_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1200\/JCO.1983.1.4.255","volume":"1","author":"MA Knowling","year":"1983","unstructured":"Knowling MA, Harwood AR, Bergsagel DE. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol. 1983;1(4):255\u201362.","journal-title":"J Clin Oncol"},{"key":"3015_CR5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2407-6-118","volume":"6","author":"D Knobel","year":"2006","unstructured":"Knobel D, Zouhair A, Tsang RW, Poortmans P, Belkac\u00e9mi Y, Bolla M, et al. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer. 2006;6:118.","journal-title":"BMC Cancer"},{"issue":"1","key":"3015_CR6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijrobp.2005.06.039","volume":"64","author":"M Ozsahin","year":"2006","unstructured":"Ozsahin M, Tsang RW, Poortmans P, Belkac\u00e9mi Y, Bolla M, Din\u00e7bas FO, et al. Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients. Int J Radiat Oncol Biol Phys. 2006;64(1):210\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"3015_CR7","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3","volume":"85","author":"C Alexiou","year":"1999","unstructured":"Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999;85(11):2305\u201314.","journal-title":"Cancer"},{"key":"3015_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0360-3016(89)90008-4","volume":"16","author":"DA Frassica","year":"1989","unstructured":"Frassica DA, Frassica FJ, Schray MF, Sim FH, Kyle RA. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 1989;16:43\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3015_CR9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2008.07421.x","volume":"144","author":"GM Dores","year":"2009","unstructured":"Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS, Devesa SS. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol. 2009;144(1):86\u201394.","journal-title":"Br J Haematol"},{"key":"3015_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1756-8722-2-41","volume":"2","author":"MU Jawad","year":"2009","unstructured":"Jawad MU, Scully SP. Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database. J Hematol Oncol. 2009;2:41.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"3015_CR11","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1177\/0194599813481334","volume":"148","author":"D Gerry","year":"2013","unstructured":"Gerry D, Lentsch EJ. Epidemiologic evidence of superior outcomes for extramedullary plasmacytoma of the head and neck. Otolaryngol Head Neck Surg. 2013;148(6):974\u201381.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"3015_CR12","first-page":"101","volume":"14","author":"K Hu","year":"2000","unstructured":"Hu K, Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology (Williston Park). 2000;14(1):101\u20138. 11; discussion 11-2, 15.","journal-title":"Oncology (Williston Park)"},{"issue":"6","key":"3015_CR13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0889-8588(05)70124-6","volume":"13","author":"MA Dimopoulos","year":"1999","unstructured":"Dimopoulos MA, Kiamouris C, Moulopoulos LA. Solitary plasmacytoma of bone and extramedullary plasmacytoma. Hematol Oncol Clin North Am. 1999;13(6):1249\u201357.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9","key":"3015_CR14","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.7314\/APJCP.2015.16.9.3741","volume":"16","author":"QW Li","year":"2015","unstructured":"Li QW, Niu SQ, Wang HY, Wen G, Li YY, Xia YF, et al. Radiotherapy Alone is Associated with Improved Outcomes Over Surgery in the Management of Solitary Plasmacytoma. Asian Pac J Cancer Prev. 2015;16(9):3741\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3015_CR15","doi-asserted-by":"crossref","unstructured":"Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002;40(Suppl 8):IV-55-61","DOI":"10.1097\/00005650-200208001-00008"},{"issue":"2","key":"3015_CR16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1023002322935","volume":"14","author":"PA Wingo","year":"2003","unstructured":"Wingo PA, Jamison PM, Hiatt RA, Weir HK, Gargiullo PM, Hutton M, et al. Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control. 2003;14(2):175\u201393.","journal-title":"Cancer Causes Control"},{"key":"3015_CR17","unstructured":"Ries LAG, Young J, J.L. K, G.E. E, M.P. L, Y.D, et al. SEER Survival Monograph: Cancer Survival Among Adults: US. SEER Program, 1988\u20132001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program. 2007"},{"issue":"12","key":"3015_CR18","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348.","journal-title":"Lancet Oncol"},{"issue":"2","key":"3015_CR19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0360-3016(96)00334-3","volume":"36","author":"TW Bolek","year":"1996","unstructured":"Bolek TW, Marcus RB, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys. 1996;36(2):329\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"3015_CR20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/alr.21544","volume":"5","author":"TD Patel","year":"2015","unstructured":"Patel TD, V\u00e1zquez A, Choudhary MM, Kam D, Baredes S, Eloy JA. Sinonasal extramedullary plasmacytoma: a population-based incidence and survival analysis. Int Forum Allergy Rhinol. 2015;5(9):862\u20139.","journal-title":"Int Forum Allergy Rhinol"},{"key":"3015_CR21","first-page":"647","volume-title":"Cancer Risk Assessment Methodologies, Biomarkers, and Epidemiology","author":"MS Linet","year":"2005","unstructured":"Linet MS, Devesa SS, Morgan GJ. New perspectives on the epidemiology of hematologic malignancies and related disorders. In: Shields PG, editor. Cancer Risk Assessment Methodologies, Biomarkers, and Epidemiology. New York, NY: Marcel Dekker; 2005. p. 647\u201391."},{"issue":"1","key":"3015_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107(1):265\u201376.","journal-title":"Blood"},{"issue":"6","key":"3015_CR23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2141.2004.04834.x","volume":"124","author":"R Soutar","year":"2004","unstructured":"Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004;124(6):717\u201326.","journal-title":"Br J Haematol"},{"issue":"4","key":"3015_CR24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bjh.13870","volume":"172","author":"P Finsinger","year":"2016","unstructured":"Finsinger P, Grammatico S, Chisini M, Piciocchi A, Fo\u00e0 R, Petrucci MT. Clinical features and prognostic factors in solitary plasmacytoma. Br J Haematol. 2016;172(4):554\u201360.","journal-title":"Br J Haematol"},{"issue":"1","key":"3015_CR25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0360-3016(00)01572-8","volume":"50","author":"RW Tsang","year":"2001","unstructured":"Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, Stewart AK. Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys. 2001;50(1):113\u201320.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"3015_CR26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/ajh.21211","volume":"83","author":"S Kilciksiz","year":"2008","unstructured":"Kilciksiz S, Celik OK, Pak Y, Demiral AN, Pehlivan M, Orhan O, et al. Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group-Sarcoma Working Party. Am J Hematol. 2008;83(9):702\u20137.","journal-title":"Am J Hematol"},{"key":"3015_CR27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/1097-0142(19810801)48:3<845::AID-CNCR2820480330>3.0.CO;2-E","volume":"48","author":"R Bataille","year":"1981","unstructured":"Bataille R, Sany J. Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer. 1981;48:845\u201351.","journal-title":"Cancer"},{"issue":"8","key":"3015_CR28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hed.20821","volume":"30","author":"G Bachar","year":"2008","unstructured":"Bachar G, Goldstein D, Brown D, Tsang R, Lockwood G, Perez-Ordonez B, et al. Solitary extramedullary plasmacytoma of the head and neck--long-term outcome analysis of 68 cases. Head Neck. 2008;30(8):1012\u20139.","journal-title":"Head Neck"},{"issue":"2","key":"3015_CR29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ijrobp.2010.11.037","volume":"82","author":"R Sasaki","year":"2012","unstructured":"Sasaki R, Yasuda K, Abe E, Uchida N, Kawashima M, Uno T, et al. Multi-institutional analysis of solitary extramedullary plasmacytoma of the head and neck treated with curative radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82(2):626\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3015_CR30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1099-1069(199609)14:3<111::AID-HON575>3.0.CO;2-G","volume":"14","author":"A Aviles","year":"1996","unstructured":"Aviles A, Huerta-Guzman J, Delgado S, Fernadez A, Diaz-Maqueo JC. Improved outcome in solitary bone plasmacytoma with combined therapy. Hematol Oncol. 1996;14:111\u20137.","journal-title":"Hematol Oncol"},{"key":"3015_CR31","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2002-08-2441","volume":"101","author":"S Kumar","year":"2003","unstructured":"Kumar S, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Wellik L, Witzig TE, Gertz MA, Kyle RA, Greipp PR, Rajkumar SV. Prognostic value of angiogenesis in solitary bone plasmacytoma. Blood. 2003;101:1715\u20137.","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1186\/s12885-017-3427-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T00:00:00Z","timestamp":1498176000000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-3015-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T10:57:06Z","timestamp":1601290626000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-3015-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3015"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-3015-5","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12885-017-3427-x","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]},"article-number":"13"}}